News

Hexoskin Presenting at the Emerging Medtech Summit

Hexoskin - LSI - Emerging Medtech Summit 2022 - Pierre-Alexandre Fournier - CEO

Pierre-Alexandre Fournier, CEO of Hexoskin was selected as an Innovation Leader for the #LSIUSA22 Emerging Medtech Summit. Hexoskin's CEO will present at the event on March 15-18, 2022, and announce exciting new products and partnerships aimed to help patients have better access to healthcare.

Pierre-Alexandre has been involved in health sensor development and artificial intelligence projects for over 15 years and advises many public and private organizations on these topics in the US, Canada and Europe. Pierre-Alexandre is also an advocate for transparency in healthcare, patient empowerment, and healthcare innovation through design.

Hexoskin Smart Garments utilize embedded textile sensors to continuously monitor vital signs. Hexoskin smart clothing is capable of monitoring cardiac, pulmonary, activity, and sleep digital biomarkers.

The Emerging Medtech Summit will feature 150 vetted presenting companies, panel sessions, 1:1 meetings, and networking opportunities.

Join us this week at #BIODigital International Convention 2020!

Hexoskin is thrilled to attend once again the upcoming BIODigital International Convention 2020, and connect with other members of the life science community. This year the meetings will transition to a virtual event format in which Hexoskin will take part. Pierre-Alexandre Fournier, co-founder, and CEO of Hexoskin will speak on the panel:

Can AI Prevent Epidemics? (Available on demand).

The panel is hosted by Annastasiah Mudiwa Mhaka, PhD, Co-founder and Convenor of the Alliance for Artificial Intelligence in Healthcare (AAIH) Convenor, former President; Founder; Mawambo Lifesciences. Our CEO will be joined in this panel by leaders in government, technology, venture capital, and health care to discuss the potential for using AI to protect us from the next pandemic or superbug. The world is more vulnerable than ever to outbreaks and remains ill-prepared to predict, prevent, detect, and respond to a significant pandemic. The panel will cover how advancements in artificial intelligence (AI) and machine learning (ML) tools and algorithms can improve the prediction of infectious disease outbreaks and prevent them from causing devastating pandemics. The panel participants will also discuss the kind of innovative public-private partnerships that can be used to develop and test new AI tools for epidemic prevention. 

Hexoskin will also demonstrate how the industry can leverage Hexoskin sensors, clinical solutions, and AI to fulfill the increasing demand for real-world evidence. Pharma and CROs interested in digital biomarkers are invited to reach out to our team to get insights on how clinical-grade wearable sensors and AI software can facilitate remote trials and monitor patients from home.

A CONNECTED HEALTH PLATFORM BUILT AROUND
YOU AND THE PATIENT

Hexoskin is the world leader in smart clothing and body sensing technologies.

The Hexoskin Connected Health Platform is the fastest growing platform available to collect Real World Evidence and publish results. Hexoskin is the leading clinically validated solution that collects continuously precise ECG, Respiratory & Activity & Sleep data.

Thousands of professionals, researchers, and students from universities, research institutions, colleges, and private organizations are leveraging the precise data collected by our comfortable and non-invasive Smart Garments. Our clients appreciate our accessible solutions such as the Hexoskin Dashboards, Open API, and Apps to manage, visualize, analyze, and export raw & processed data.

With over 85 scientific publications & validation studies published since 2012, Hexoskin is the solution of choice to generate precise physiological health data. Hexoskin’s team of experts supports researchers and investigating teams to design and manage their multi-sites studies.

Request an e-meeting with our team to discuss your needs and learn more about how Hexoskin can support remote patient-centered studies.